Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Oncocyte Corporation - Common Stock
(NQ:
OCX
)
3.200
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Oncocyte Corporation - Common Stock
OncoCyte’s (NASDAQ:OCX) Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Via
AB Newswire
OncoCyte's Innovative Approach: Potential in Precision Diagnostics
June 05, 2024
Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For...
Via
TheNewswire.com
3 Penny Stocks That Insiders Are Buying
May 07, 2024
Penny stocks are a risky business but following the insiders to your next trade can alleviate some of the risks; these are the three hottest insider buys.
Via
MarketBeat
Oncocyte's VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
September 18, 2023
Via
ACCESSWIRE
Oncocyte to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
September 06, 2023
Via
ACCESSWIRE
Oncocyte's VitaGraft Kidney Transplant Diagnostic Test Receives CMS Coverage
August 28, 2023
Via
ACCESSWIRE
Oncocyte Reports Second Quarter 2023 Financial Results
August 10, 2023
Via
ACCESSWIRE
Oncocyte to Participate in 8th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
August 08, 2023
Via
ACCESSWIRE
Oncocyte Regains Compliance With Nasdaq Listing Requirements
August 09, 2023
Via
ACCESSWIRE
Oncocyte To Announce Second Quarter 2023 Financial Results
August 03, 2023
Via
ACCESSWIRE
EchelonDx and Oncocyte Announce Collaboration to Create Seamless Informatics Software to Scale Proprietary Clinical Test Offerings
June 15, 2021
From
Echelon Diagnostics, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
